Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

74
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics profiles of sex hormone-binding globulin are associated with subclinical atherosclerosis in men with HIV.

Genome medicine·2026
Same author

Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

Clinical pharmacology and therapeutics·2026
Same author

Exploring the association between common genetic deletions and aging: insights from the Canadian Longitudinal Study on Aging.

GeroScience·2026
Same author

Microbial reactivation of host androgens directs enteric neuronal regulation of gut motility.

Nature neuroscience·2026
Same author

Development of a Novel Holistic Assessment Strategy of TAVI-Induced Flow Restoration via Dimensionality Reduction Techniques.

Cardiovascular engineering and technology·2026
Same author

Influence of inflammation on drug transporter expression in human airway epithelia: Implications for inhaled drug pharmacokinetics.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Finding the dispersion number (D<sub>N</sub>) of the dispersion model from perfused rat and human liver studies.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

The regulatory potential of cytochrome P450-adrenodoxin interactions: Insights toward understanding redox partner regulation in drug metabolizing enzymes.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Enantioselective determination of methylone and its major phase 1 metabolites in various biological matrices and stereochemical stability of methylone enantiomers.

Drug metabolism and disposition: the biological fate of chemicals·2026
See all related articles

Related Experiment Video

Updated: Apr 10, 2026

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
12:11

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

Published on: February 27, 2020

7.4K

Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential.

Guillaume Margaillan1, Michèle Rouleau1, Kathrin Klein1

  • 1Pharmacogenomics Laboratory, Centre Hospitalier Universitaire (CHU) de Québec and Faculty of Pharmacy, Université Laval, Québec, Canada (G.M., M.R., P.C., L.V., C.G.); Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen, Tübingen, Germany (K.K., U.M.Z.); Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina (J.K.F., P.C.S.); Canada Research Chair in Pharmacogenomics (C.G.).

Drug Metabolism and Disposition: the Biological Fate of Chemicals
|June 17, 2015
PubMed
Summary
This summary is machine-generated.

This study quantified 14 hepatic UDP-glucuronosyltransferases (UGTs) using targeted proteomics. UGT2B7 was most abundant, with significant interindividual variability observed in UGT expression and activity.

More Related Videos

Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry
11:54

Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry

Published on: March 23, 2020

10.5K
A Spin-Tip Enrichment Strategy for Simultaneous Analysis of N-Glycopeptides and Phosphopeptides from Human Pancreatic Tissues
09:16

A Spin-Tip Enrichment Strategy for Simultaneous Analysis of N-Glycopeptides and Phosphopeptides from Human Pancreatic Tissues

Published on: May 4, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 10, 2026

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
12:11

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

Published on: February 27, 2020

7.4K
Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry
11:54

Detection of Protein Ubiquitination Sites by Peptide Enrichment and Mass Spectrometry

Published on: March 23, 2020

10.5K
A Spin-Tip Enrichment Strategy for Simultaneous Analysis of N-Glycopeptides and Phosphopeptides from Human Pancreatic Tissues
09:16

A Spin-Tip Enrichment Strategy for Simultaneous Analysis of N-Glycopeptides and Phosphopeptides from Human Pancreatic Tissues

Published on: May 4, 2022

2.8K

Area of Science:

  • Pharmacology
  • Biochemistry
  • Proteomics

Background:

  • Phase II metabolism is crucial for drug and endogenous molecule bioactivity.
  • UDP-glucuronosyltransferases (UGTs) are key enzymes in hepatic glucuronidation.
  • Understanding hepatic UGT expression is vital for drug development and personalized medicine.

Purpose of the Study:

  • To determine the expression profiles of 14 hepatic UDP-glucuronosyltransferases (UGTs) in human liver samples.
  • To quantify the absolute concentrations and assess the activity of hepatic UGTs.
  • To investigate the interrelationships and variability in UGT expression.

Main Methods:

  • Targeted proteomics was employed to quantify 14 hepatic UGTs in 48 liver samples.
  • Nano-ultra-performance liquid chromatography with tandem mass spectrometry (nano-UPLC-MS/MS) was utilized for sensitive analysis.
  • Glucuronidation activity was measured using specific probe substrates.

Main Results:

  • UGT2B7 was identified as the most abundant hepatic UGT, with UGT1A1, UGT1A4, UGT2B4, and UGT2B15 also highly expressed.
  • The five most abundant UGTs accounted for 81% of the total measured hepatic UGTs.
  • Significant interindividual variability in UGT concentrations and activities was observed, with strong correlations noted between UGT1A4 and other UGTs, and between UGT2B4/UGT2B7.

Conclusions:

  • Multiplexed targeted quantitative proteomics accurately assesses hepatic UGT concentrations and glucuronidation potential.
  • The study provides comprehensive absolute hepatic concentrations for 14 UGTs.
  • Co-regulated expression patterns among the most abundant hepatic UGTs were identified, expanding understanding of hepatic UGT profiles.